These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18630234)

  • 21. [Treatment of acute diarrhea: prescription patterns by private practice pediatricians].
    Uhlen S; Toursel F; Gottrand F;
    Arch Pediatr; 2004 Aug; 11(8):903-7. PubMed ID: 15288079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue.
    Paredes P; de la Peña M; Flores-Guerra E; Diaz J; Trostle J
    Soc Sci Med; 1996 Apr; 42(8):1141-53. PubMed ID: 8737432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents.
    Khunti K; Kinsella B
    Age Ageing; 2000 Sep; 29(5):451-3. PubMed ID: 11108419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug promotional practices in Mumbai: a qualitative study.
    Roy N; Madhiwalla N; Pai SA
    Indian J Med Ethics; 2007; 4(2):57-61. PubMed ID: 18630221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data.
    Crea G; Galizzi MM; Linnosmaa I; Miraldo M
    J Health Econ; 2019 May; 65():153-169. PubMed ID: 31022628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing pattern of analgesics in orthopedic in-patient department at tertiary care hospital in Guwahati, Assam, Northeast India.
    Choudhury DK; Bezbaruah BK
    Indian J Pharmacol; 2016; 48(4):377-381. PubMed ID: 27756947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
    Cleary JD
    J Pharm Technol; 1992; 8(1):27-9. PubMed ID: 10118197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Our struggle to implement best practices: the example of antibiotic prescription for respiratory tract infection.
    Norman WV
    Fam Pract; 2015 Aug; 32(4):365-6. PubMed ID: 26163508
    [No Abstract]   [Full Text] [Related]  

  • 33. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical promotion: don't throw the baby out with the bathwater.
    Dubois RW
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-96-103. PubMed ID: 14527238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diarrhoea-related knowledge and practice of physicians in urban slums of Kolkata, India.
    Kanungo S; Mahapatra T; Bhaduri B; Mahapatra S; Chakraborty ND; Manna B; Sur D
    Epidemiol Infect; 2014 Feb; 142(2):314-26. PubMed ID: 23659645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining product risk in context. Market withdrawal of zomepirac as a case study.
    Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH
    JAMA; 1993 Oct; 270(16):1937-42. PubMed ID: 8411550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007-2013.
    Sharma P; Finley R; Weese S; Glass-Kaastra S; McIsaac W
    PLoS One; 2017; 12(7):e0181957. PubMed ID: 28750020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment practice of acute cystitis on the basis of national prescription data].
    Juhász Z; Benkő R; Matuz M; Viola R; Soós G; Hajdú E
    Orv Hetil; 2014 Apr; 155(15):590-6. PubMed ID: 24704771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of antibiotic prescription use for inflamed epidermal inclusion cysts.
    Poonawalla T; Uchida T; Diven DG
    J Cutan Med Surg; 2006; 10(2):79-84. PubMed ID: 17241579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.